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Abstract
Background: While diabetes mellitus (DM) is a known risk factor for tuberculosis, the prevalence among TB patients in India
is unknown. Routine screening of TB patients for DM may be an opportunity for its early diagnosis and improved
management and might improve TB treatment outcomes. We conducted a cross-sectional survey of TB patients registered
from June–July 2011 in the state of Kerala, India, to determine the prevalence of DM.
Methodology/Principal Findings: A state-wide representative sample of TB patients in Kerala was interviewed and
screened for DM using glycosylated hemoglobin (HbA1c); patients self-reporting a history of DM or those with HbA1c
$6.5% were defined as diabetic. Among 552 TB patients screened, 243(44%) had DM – 128(23%) had previously known DM
and 115(21%) were newly diagnosed - with higher prevalence among males and those aged .50years. The number needed
to screen(NNS) to find one newly diagnosed case of DM was just four. Of 128 TB patients with previously known DM,
107(84%) had HbA1c $7% indicating poor glycemic control.
Conclusions/Significance: Nearly half of TB patients in Kerala have DM, and approximately half of these patients were
newly-diagnosed during this survey. Routine screening of TB patients for DM using HbA1c yielded a large number of DM
cases and offered earlier management opportunities which may improve TB and DM outcomes. However, the most cost-
effective ways of DM screening need to be established by futher operational research.
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Introduction
Diabetes Mellitus (DM) almost triples the risk of developing
tuberculosis (TB) [1–4]. India, the nation with the highest number
of TB cases in the world, is also undergoing epidemic growth in
DM rates. The estimated prevalence of DM in India in 2010 was
51 million and this is projected to increase to 70 million by 2025
[5,6]. In India, 15% of pulmonary tuberculosis cases have been
estimated to be attributable to DM [7]. An analysis of nutrition
and DM changes in India also suggests that increased DM
prevalence between 1998 and 2008 contributed to an increase in
the total number of TB cases in the country which exceeded the
rate of population growth in the same time period [8]. These
findings highlight the impact of the DM epidemic on TB incidence
rates in the country.
A recent systematic review of the effect of DM on TB treatment
outcomes showed that DM may delay sputum culture conversion,
may increase the case fatality rate during treatment, and may
increase relapse rates of TB after successful completion of
treatment [9]. A study from Kerala shows that non-drug resistant
TB patients with DM were more likely to fail first line TB
treatment as compared to those without DM [10]. Therefore,
active screening for DM among TB patients may provide an
opportunity to identify previously undiagnosed diabetes and
improve TB treatment outcomes through optimum diabetic care.
However, neither international guidelines nor India’s Revised
National TB Control Programme (RNTCP) currently recommend
active screening of TB patients for detection of DM.
DM is common in the south Indian state of Kerala (population
34.6 million), with an estimated community prevalence of 16% to
20% [11,12]. We therefore conducted this study to determine the
overall prevalence of DM among TB patients and to assess
whether routine screening of TB patients for DM within a
programme setting might yield previously undiagnosed DM cases,
PLOS ONE | www.plosone.org 1 October 2012 | Volume 7 | Issue 10 | e46502
offering an opportunity for earlier detection and treatment of DM.
The specific objectives of this study were to determine (i) the
overall prevalence of DM (self-reported and newly diagnosed)
among TB patients registered for treatment under RNTCP in
Kerala state (ii) additional yield of previously unknown DM as
measured by glycosylated haemoglobin (HbA1c) and the Number
needed to screen (NNS) to find a new case of DM and (iii) the
factors associated with DM among TB patients.
Methods
Study Design
This was a cross-sectional study of a sample of TB patients
diagnosed and registered in 2011 in which self-report and HbA1c
was used to diagnose DM.
Study Setting
The study was conducted in Kerala, the southernmost state of
India. In 2010, approximately 25,000 patients were diagnosed and
treated through 73 TB reporting units statewide [13]. According
to national guidelines [14], sputum smear microscopy is performed
for all TB suspects. Patients are diagnosed with pulmonary TB
(PTB) if at least one initial sputum sample contains acid fast bacilli.
Smear negative PTB cases are diagnosed by chest radiograph
subsequent to negative results for repeated sputum smear
microscopy, after two weeks of the first results. Extra-pulmonary
TB (EPTB) cases are diagnosed by a combination of histopathol-
ogy, mycobacteriology and/or clinical features. All TB patients are
treated with a rifampicin containing, fully intermittent (thrice
weekly), standardized treatment regimen delivered under direct
observation. Patients are registered for treatment in one of the
designated TB units of the state and monitored for their treatment
outcome. TB cases are further classified as per standard WHO
definitions [15]. Kerala state has been proactive and ahead of the
national efforts in providing diagnostic and treatment services for
DM at secondary care level within its general health system at
subsidized rates for the patients [16].
The national programme dealing with all non-communicable
diseases including diabetes (NPCDCS for National programme for
prevention and control of Cancer, Diabetes, Cardiovascular
diseases and Stroke) is still in its early stages in India and is being
piloted in 30 districts across the country with plans to extend it to
100 districts by the end of 2012. However, the Government of
India is committed to achieve nationwide expansion in the 12th
five year plan period (2012–17) [17]. In these pilot districts,
diagnostic and treatment services for DM have been decentralized
to primary care level, free of cost to the patients.
Sample size and Sampling
All patients aged .15 years diagnosed and registered with any
type of TB in Kerala’s 73 TB Units between June and July 2011
were eligible for this study. The sample size for the study was
calculated based on an estimated prevalence of DM in TB patients
of 25% with a precision of 5% and a design effect of two. Cluster
sampling method was chosen with each TB unit considered a
cluster. Of the 73 TB Units, 30 were selected randomly to create a
representative sample of the state. Of the TB units selected, 22 TB
units were predominantly rural and 8 TB units were predomi-
nantly urban, in line with the expected rural-urban distribution of
the population in the state of Kerala. The number of patients
enrolled in each cluster was proportionate to number of TB cases
notified from each selected TU. In each TB unit, consecutively
registered TB patients were enrolled until the required sample was
achieved. The names of the TB units, sample size planned from
each cluster and sample size achieved are shown in the table.
(Table 1. Details of the 30 TB Units (clusters) selected by cluster
sampling for the study, Kerala, India, June–July 2011). The
location of TB units selected is shown in the map. (Figure 1:
Sampled TB units in Kerala to estimate the prevalence of Diabetes
Mellitus among TB patients)
Data Collection and analysis
Data were collected using a structured questionnaire to elicit
demographic and clinical variables including a history of diabetes.
For patients consenting to DM screening, blood samples were
collected within one month of diagnosis of TB and glycosylated
hemoglobin (HbA1c) levels were measured from whole blood
using High Pressure Liquid Chromatography on a Biorad D10
Machine according to standard procedures, an NGSP (National
Glycohemoglobin Standardization Program) accepted method
with low co-efficient of variation and less likely to be affected by
interfering substances. An HbA1c value of 6.5% or above was
considered diagnostic of DM, in line with recommendations of
American Diabetes Association and WHO [18–20]. For patients
with self-reported DM, a glycosylated hemoglobin (HbA1c) level
.7% was taken to indicate poorly controlled disease [21]. We
chose to measure glycosylated hemoglobin level as a tool to
diagnose DM as it has multiple advantages over traditional fasting
plasma glucose measurement. First, it is a valid method and is now
recommended by all the leading technical agencies around the
Figure 1. Sampled TB units in Kerala to estimate the
prevalence of Diabetes Mellitus among TB patients.
doi:10.1371/journal.pone.0046502.g001
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globe. Second, it is very convenient for the patient as blood sample
can be drawn at the time of initial visit and does not require
patient preparation in terms of being in the fasting state for
8 hours, which often places unnecessary burden on very sick
patients. Third, it is least influenced by temporary changes in the
levels of blood glucose due to various factors including acute
infection like Tuberculosis.
We used Epi Info 7 (Version 7.0.8.0) to analyze the data and
performed a complex sample analysis to account for the cluster
sampling methodology [22]. The main outcomes for analysis were
the number and proportion (with 95% confidence interval) of TB
patients with a diagnosis of DM (previously known and newly
diagnosed), stratified by age, sex, place of residence and type of
TB. Odds ratios with 95% confidence intervals have been used to
describe the differences between groups. Multivariate analysis
using logistic regression was done to calculate adjusted odds ratios.
Only variables that were statistically significant (p,0.05) in
bivariate analysis were considered for multivariate analysis.
Ethics approval
Written informed consent was taken from all the study
participants and from the parents in case of minors, ie, for
participants of age 15 to 18 years, before enrollment in the study
and those TB patients who were diagnosed to be having DM were
linked to standard care available in the government health system
which included counseling, lifestyle modification, specialist’s
consultation, anti-diabetic medications including insulin provided
free of cost and management of complications. The study was
approved by the ethics committee of National Tuberculosis
Institute (NTI), Bangalore, India and the Ethical Advisory Group
of The International Union against Tuberculosis and Lung
Diseases (The Union).
Results
The overall prevalence of DM among TB patients disaggregat-
ed by age, sex, residence and type of TB is shown in Table 2
(Table 2 Prevalence of Diabetes Mellitus among tuberculosis
Table 1. Details of the 30 TB Units (clusters) selected by cluster sampling for the study, Kerala, India, June–July 2011.
Name of the TB unit
Type of TB
Unit Population






Adoor Rural 525924 100 32 30
Alathur Rural 431834 75 21 21
Chavakkad Rural 561856 69 19 12
Cherthala Rural 554693 74 25 25
Chirayinkeezhu Rural 536603 71 18 0
Chittur Rural 448880 107 30 30
Kochi Urban 498868 84 25 25
Irinjalakkuda Rural 548386 65 22 20
Kasaragod Rural 502522 62 19 8
Karunagappally Rural 467111 82 27 27
Kollam_DTC Urban 803899 120 32 25
Kothamangalam Rural 248208 39 11 11
Kottayam Urban 681484 124 33 34
Koyilandy Urban 520464 70 22 22
Mavelikkara Rural 561102 100 29 29
Mukkam Rural 447704 47 16 16
Neyyattinkara Rural 508572 64 19 0
Ottapalam Rural 485813 92 24 24
Painavu Rural 259416 18 7 7
Pala Rural 424809 51 17 17
Palakkad_DTC Urban 545474 100 36 36
Payyannur Rural 463532 53 12 12
Peroorkada Urban 500110 60 17 0
Perumbavoor Rural 420324 70 21 13
Ponnani Rural 423191 44 14 15
Punalur Rural 483612 78 25 25
Thalassery Urban 504638 64 20 16
Thiruvalla Urban 468174 60 17 17
Wadakkanchery Rural 521066 81 24 19
Wayanad_DTC Rural 265509 35 15 16
Total 650 552
doi:10.1371/journal.pone.0046502.t001
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patients registered for treatment in the state of Kerala, India,
June–July 2011). There were 552 patients [mean (SD) age 46 (15)
years] enrolled in the study. Three quarters of the patients were
male and the majority were from a rural setting. New TB patients
constituted 86% of all patients, and of these 65% had smear-
positive pulmonary TB (Table 2).
Of 552 TB patients assessed, 243 (44%) were found to have DM
(Table 2). The prevalence of DM was higher among males, those
aged 50 years and above and among smear positive TB cases,
particularly among Relapse TB cases.
Of 243 diabetics, 128 (23%) TB patients self-reported a previous
diagnosis of DM and 115 (21%) were newly diagnosed to have
DM, an additional yield of about 47%. (Table 3 Additional Yield
of new cases of Diabetes Mellitus and Number Needed to Screen
to diagnose a new case of DM among tuberculosis patients in the
state of Kerala, India, June–July 2011). After excluding previously
known DM, the number of TB patients that needed to be screened
(NNS) to find one new case of DM was approximately 4 (Table 3).
The NNS ranged between 2–6 across all categories except for
those aged 15–24 years in whom it was 53.
Results of the bivariate and multivariate analysis are presented
in Table 4. (Table 4 Factors associated with Diabetes Mellitus
among tuberculosis patients registered for treatment in the state of
Kerala, India, June–July 2011). Male sex and age above 50 years
were significantly associated with a diagnosis of DM and remained
independently associated even after adjusting for other variables in
a logistic regression model (Table 4).
Of 128 patients with a self-reported history of DM, 107 (84%)
(95% CI 76.0–89.5) had a glycosylated haemoglobin level equal to
or more than 7%, indicating poorly controlled DM.
Discussion
We found a high prevalence of DM amongst TB patients
registered under RNTCP in the state of Kerala, India and this was
significantly associated with male sex and age above 50 years.
About one quarter of the patients gave a self-reported history of
DM, and this was more common in those living in an urban
environment and aged 50 years and above. This association with
urban residence may indicate lifestyle practices that predispose to
DM or better access to diagnosis of DM in urban settings. Of
concern was the finding that the majority of these self-reported
patients had poorly controlled DM, defined as glycosylated
haemoglobin levels greater than or equal to 7%. This is as per
the recommended glycemic goals for nonpregnant adults by
American Diabetes Association which is HbA1c level of ,7%
corresponding to a preprandial capillary plasma glucose 70–
130 mg/dl (3.9–7.2 mmols/l) to define the control status of
diabetes [21]. In those with no self-reported history of DM, over
one quarter had glycosylated haemoglobin levels greater than or
equal to 6.5%, which is recognised by WHO as diagnostic of DM.
In total, nearly half (44%, 95% CI 38.8–49.3) of the TB patients in
Kerala were found to have DM, the highest reported prevalence of
DM among TB patients to date. Furthermore 115 (21%) TB
patients were found to have previously-undiagnosed DM. These
Table 2. Prevalence of Diabetes Mellitus among tuberculosis patients registered for treatment in the state of Kerala, India, June–
July 2011.
Characteristic
Number of TB patients whose DM status
was ascertained Number with DM
Prevalence of DM (95%
CI)
Total 552 243 44.0 (38.8–49.3)
Sex
Male 420 208 49.5 (43.6–55.4)
Female 132 35 26.5 (19.1–33.9)
Age (years)
15–24 57 4 7.0 (0.6–13.4)
25–34 70 15 21.4 (10.6–32.2)
35–44 114 44 38.6 (29.1–48.1)
45–54 134 74 55.2 (46.5–63.9)
55–64 106 67 63.2 (51.7–74.7)
$65 71 39 54.9 (42.1–67.7)
Residence
Urban 107 51 47.6 (35.8–59.5)
Rural 445 192 43.1 (37.9–48.4)
Type of TB
New Smear Positive Pulmonary TB 307 157 51.1 (44.3–57.9)
New Smear Negative Pulmonary TB 37 11 29.7 (17.7–41.7)
New Extra-pulmonary TB 128 36 28.1 (18.4–37.8)
Relapse 35 20 57.1 (40.8–73.5)
Treatment after Failure 19 9 47.3 (24.5–70.2)
Treatment after Default 26 10 38.4 (18.3–58.5)
TB-Tuberculosis; DM- Diabetes Mellitus; CI-Confidence Interval; Number with DM includes self-reported, previously known cases and those newly diagnosed with a
glycosylated hemogolobin level of $6.5%.
doi:10.1371/journal.pone.0046502.t002
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Table 3. Additional Yield of new cases of Diabetes Mellitus and Number Needed to Screen to diagnose a new case of DM among
tuberculosis patients in the state of Kerala, India, June–July 2011.
Characteristic
Number of TB patients












Total 552 128 115 47% 3.7
Sex
Male 420 108 100 48% 3.1
Female 132 20 15 43% 7.5
Age (years)
15–24 57 3 1 25% 52.6
25–34 70 4 11 73% 6.0
35–44 114 19 25 57% 3.8
45–54 134 44 30 41% 3.0
55–64 106 38 29 43% 2.3
$65 71 20 19 49% 2.6
Residence
Urban 107 37 14 27% 5.0
Rural 445 91 101 53% 3.5
Type of TB
New Smear Positive Pulmonary TB 307 87 70 45% 3.1
New Smear Negative Pulmonary TB 37 4 7 64% 4.7
New Extra-pulmonary TB 128 15 21 58% 5.3
Relapse 35 12 8 40% 3.3
Treatment after Failure 19 7 2 22% 6.0
Treatment after Default 26 3 7 70% 3.3
TB-Tuberculosis; DM- Diabetes Mellitus; NNS-Number needed to screen is defined as the reciprocal of the prevalence of newly diagnosed DM after excluding self-
reported previously known cases of DM.
doi:10.1371/journal.pone.0046502.t003
Table 4. Factors associated with Diabetes Mellitus among tuberculosis patients registered for treatment in the state of Kerala,
India, June–July 2011.
Characteristic Unadjusted Odds Ratio (95% CI) Adjusted Odds Ratio (95% CI) #
Sex
Male 2.7 (1.8–4.0)* 2.3 (1.5–3.6)*
Female Ref Ref
Age (years)
$50 3.0 (2.2–4.3)* 2.8 (2.0–4.0)*
,50 Ref Ref
Residence




Previously treated 1.2 (0.8–2.0)
TB-Tuberculosis; DM- Diabetes Mellitus; NA-Not applicable.
*P value less than 0.05;
#- adjusted for age and sex using Logistic regression.
doi:10.1371/journal.pone.0046502.t004
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findings are an alarming signal that DM should be considered and
investigated in all TB patients in Kerala. This is highly justified
given the high returns in terms of additional yield of newly
diagnosed DM cases found in our study. The number needed to
screen (NNS) to find one new case of DM was just four overall and
ranged mainly from two to six, with the exception of the age group
15–24 years in whom it was about 50. This indicates that the
strategy of routine screening of all TB patients for DM is likely to
be cost-effective.
The high prevalence of DM amongst TB patient in the state
follows a similar pattern of high prevalence of DM in the general
population. Prevalence of DM as reported by the community
serveys using blood sugar estimation among the general adult
population in the state is high (16–20%) and is higher than that of
the rest of the country [12]. On the other hand, prevalence of
tuberculosis transmission, is less in Kerala compared to the rest of
the country [23]. TB patients of Kerala are older than those in the
rest of India and DM could be one of the important factors
influencing tuberculosis incidence in Kerala.
The strengths of this study are that large numbers of TB patients
were consecutively enrolled in 30 reporting units across Kerala
state, India, and therefore this cohort is probably representative of
the state. However, this may not be representative of the situation
in India because the prevalence of DM in Kerala is higher than
that reported nationally and from other states in the country [24].
Another strength is that glycosylated haemoglobin levels were
measured on all patients. This measurement provides an index of
blood glucose levels over a period 2–3 months and is not subject to
the rapid swings that can occur with random and fasting blood
glucose measurements. Blood glucose levels at a specific moment
in time can reflect recent diet and may also be affected by
physiologic stress such as active tuberculosis as well as anti-TB
treatment. Possible limitations of the study include the lack of
information on factors such as alcohol intake or use of other drugs
which might affect glycosylated haemoglobin levels. As an
infectious disease, TB may temporarily elevate blood glucose
levels resulting in false-positive diagnoses of diabetes if investiga-
tions are done too early. Several observational studies have shown
that prevalence of hyperglycemia decreases with TB treatment and
hence more research with multiple measurements during the
course of treatment is required to define the optimal timing of
screening for DM [25].
We know of no other prospective study that has measured
glycosylated haemoglobin levels in patients with TB in India.
There have been studies conducted in India assessing the
prevalence of DM in TB patients by meausrement of random
and fasting blood glucose levels, and these have found prevalence
levels that vary from 2% to 20% [26–30]. Routine screening of TB
patients for DM using random and fasting blood glucose level
measurements by TB service providers in Kerala had reported a
prevalence of 26% among TB patients of age 15 years or more
[31]. Routine screening of multi drug resistant TB patients treated
under RNTCP in Kerala with fasting and post meal blood glucose
levels showed a prevalence of DM of 40%. A study similar to our
study measuring glycosylated haemoglobin by Blanca et. al in
Texas where community prevalence of DM was 19% reported a
39% prevalence of DM among TB patients [32].
Policy implications
This study has important policy implications. First, it is
advisable to perform similar studies in different states in India
using the same methodology in order to get a good measure of
DM prevalence in TB patients across the country. Second, as is
the case with HIV in sub-Saharan Africa, it will be essential to ask
TB patients routinely about whether or not they have DM. If
patients do give a self-reported history of DM, then they must be
referred to appropriate DM care as most of the patients in this
study had poorly controlled diabetes disease. TB patients with DM
have an increased risk of death and this may be reduced through
better DM control and treatment. Third, the study suggests it is
important to routinely and actively screen all TB patients for DM,
including those who do not self-report the disease. The major
question is how to do this most effectively and efficiently [33].
Although glycosylated haemoglobin would appear to be the best
way to screen as it is relatively unaffected by active TB and anti-
TB drugs, it is a costly laboratory investigation which might be
difficult to scale up and to use in peripheral health facilities. This
requires a cost-effectiveness analysis. Fourth, there is limited
information on various aspects of interaction between TB and DM
including optimal tools and strategies for collaboration. This
urgently calls for research - both clinical and operational research -
to understand these interactions better and optimize the interven-
tion strategies [25]. Finally, it is important to have a well
functioning non-communicable disease control programme linked
with the TB control programme in settings where the prevalence
of DM among TB patients is high. The recently published WHO-
Union collaborative framework for care and control of DM-
associated tuberculosis is a good template for action and should be
considered for implementation by the national programmes [25].
Conclusions
In conclusion, this study has shown a high prevalence of DM in
patients with active TB, both for self-reported DM and for patients
in whom the disease was not suspected, and supports routine
screening of TB patients for DM. However, the best way of doing
this needs to be established by futher operational research studies.
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